“Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses”. Cell93 (3): 373–83. (1998). doi:10.1016/S0092-8674(00)81166-6. PMID9590172.
Craiglow, B. G.; King, B. A. (2015). “Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy”. JAMA Dermatology151: 1110–2. doi:10.1001/jamadermatol.2015.1520. PMID26107994.
“Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses”. Cell93 (3): 373–83. (1998). doi:10.1016/S0092-8674(00)81166-6. PMID9590172.
Craiglow, B. G.; King, B. A. (2015). “Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy”. JAMA Dermatology151: 1110–2. doi:10.1001/jamadermatol.2015.1520. PMID26107994.